Phase ii clinical trial of chemotherapy-naive patients ≥ 70 years of age treated with erlotinib for advanced non-small-cell lung cancerJACKMAN, David M; YEAP, Beow Y; FREIDLIN, Boris et al.Journal of clinical oncology. 2007, Vol 25, Num 7, pp 760-766, issn 0732-183X, 7 p.Article

Erlotinib Plus Bevacizumab in Previously Treated Patients With Malignant Pleural MesotheliomaJACKMAN, David M; KINDLER, Hedy L; YEAP, Beow Y et al.Cancer. 2008, Vol 113, Num 4, pp 808-814, issn 0008-543X, 7 p.Article